Technical Coverage on Pharma Stocks -- Teva Pharmaceutical Industries, AbbVie, Merck, Johnson and Johnson, and Bristol-Myers Squibb

LONDON, August 20, 2014 /PRNewswire/ --

The trading session on Tuesday, August 19, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,919.59, up 0.48% and the NASDAQ Composite closed at 4,527.51, up 0.43%. The S&P 500 finished the day 0.50% higher at 1,981.60. During the trading session nine out of ten sectors finished on a positive note. The S&P 500 Health Care Sector Index finished the day at 726.42, up 0.66%, and the index has advanced 7.42% in the previous three months. Investor-Edge has initiated coverage on the following equities: Teva Pharmaceutical Industries Ltd (NYSE: TEVA), AbbVie Inc. (NYSE: ABBV), Merck and Co. Inc. (NYSE: MRK), Johnson and Johnson (NYSE: JNJ) and Bristol-Myers Squibb Co. (NYSE: BMY). Free research on these five companies can be accessed at:  

http://investor-edge.com/register

Shares in Teva Pharmaceutical Industries gained 1.45% on Tuesday, ending the session at $52.79. A total of 3.43 million shares were traded, below its three months average volume of 4.06 million shares. The stock moved between $52.04 and $52.84 during the session. Shares in Teva Pharmaceutical Industries Ltd have advanced 0.86% in the previous three trading sessions and 31.71% on YTD basis. However, the stock has lost 3.54% in the last one month. The company's stock is trading below its 50-day moving average. The stock's 50-day moving average of $53.09 is above its 200-day moving average of $47.53. Further, shares in Teva Pharmaceutical Industries Ltd have a Relative Strength Index (RSI) of 47.78. Sign up and read the free notes on TEVA at:

http://www.Investor-Edge.com/TEVA-20Aug2014

AbbVie Inc.'s stock recorded a trading volume of 9.16 million shares, which was close to its three months average volume of 9.73 million shares. On Tuesday, the stock finished the day at $55.29, which was 1.80% higher its previous day's closing of $54.31, and registered an intraday range of $54.18 and $55.31. Shares in AbbVie Inc. have gained 2.03% in the previous three trading sessions and 0.69% in the last one month. Additionally, the company's shares are up 4.70% on YTD basis. Shares in AbbVie Inc. are trading above their 50-day and 200-day moving averages of $54.32 and $51.69, respectively. Furthermore, the stock traded at a PE ratio of 19.09 and has an RSI of 54.26. The complimentary notes on ABBV can be downloaded as in PDF format at:

http://www.Investor-Edge.com/ABBV-20Aug2014

Shares in Merck and Co. Inc. fluctuated between $58.34 and $58.95 before ending Tuesday's session 0.84% higher at $58.91. The stock reported a trading volume of 7.43 million shares, which was near its three months average volume of 8.23 million shares. Shares of the company traded at a PE ratio of 16.88. Shares in Merck and Co. Inc. have advanced 0.22% in the previous three trading sessions and 0.98% in the last one month. Moreover, the company's shares have mapped gains of 17.70% on YTD basis. Shares in Merck and Co. Inc. are trading above their 50-day and 200-day moving averages of $57.99 and $54.55, respectively. Additionally, the company's shares have an RSI of 56.89. Register for free on Investor-Edge and access the latest research on MRK at:

http://www.Investor-Edge.com/MRK-20Aug2014

On Tuesday, shares in Johnson and Johnson edged 0.25% higher, closing the day at an intra-day high of $102.96. The stock recorded a trading volume of 5.67 million shares, which was below its three months average volume of 6.17 million shares. The stock oscillated between $102.02 and $102.96 during the session. The stock traded at a PE ratio of 17.66. Shares in Johnson and Johnson have gained 0.92% in the previous three trading sessions and 1.14% in the last one month. Moreover, the company's shares have advanced 12.41% since the start of this year. Johnson and Johnson's shares are trading below their 50-day moving average. The stock's 50-day moving average of $103.00 is above its 200-day moving average of $97.16. Further, the stock has an RSI of 54.82. The complete research on JNJ is available for free at:

http://www.Investor-Edge.com/JNJ-20Aug2014

Shares in Bristol-Myers Squibb Co. advanced 0.62% on Tuesday, closing the day at an intra-day high of $50.30. The stock recorded a trading volume of 4.38 million shares, which was below its three months average volume of 7.74 million shares. The stock oscillated between $49.83 and $50.30 during the session. Shares of the company traded at a PE ratio of 27.90. Shares in Bristol-Myers Squibb Co. have advanced 0.96% in the previous three trading sessions and 2.40% in the last one month. However, the company's shares have fallen by 5.36% since the start of this year. Shares in Bristol-Myers Squibb Co. are trading above their 50-day moving average. The stock's 50-day moving average of $48.76 is below its 200-day moving average of $51.05.  Moreover, the stock has an RSI of 56.68. Free in depth research on BMY is available at:

http://www.Investor-Edge.com/BMY-20Aug2014

About Investor-Edge.com 

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

===============

EDITOR'S NOTES:

===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED